成立于1997年,較早布局中醫藥全產業,以中藥飲片為核心,以智慧藥房為抓手,打造大健康+大平臺+大數據+大服務體系
康(kang)美藥(yao)業(ye)股份有限公司(si)(600518)成(cheng)立于1997年(nian)(nian),于2001年(nian)(nian)在上交所(suo)上市。公司(si)秉承“心(xin)懷蒼生(sheng)、大愛(ai)(ai)無疆(jiang)”的核心(xin)價值(zhi)觀(guan)和(he)“用愛(ai)(ai)感動世界、用心(xin)經營健(jian)康(kang)”的經營理(li)念,在國家(jia)振興中(zhong)醫藥(yao)事(shi)業(ye)戰略指(zhi)引下,布局(ju)中(zhong)醫藥(yao)全(quan)產業(ye)鏈,以中(zhong)藥(yao)飲(yin)片(pian)為核心(xin),以智慧藥(yao)房(fang)為抓手,打造“大健(jian)康(kang)+大平臺+大數據+大服務”體系,成(cheng)為中(zhong)醫藥(yao)全(quan)產業(ye)鏈精準(zhun)服務型“智慧+”大健(jian)康(kang)產業(ye)上市企(qi)業(ye)、國家(jia)高新技術(shu)企(qi)業(ye)。
康(kang)美藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)業(ye)(ye)(ye)(ye)(ye)上(shang)(shang)至藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)材(cai)(cai)種植、藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)材(cai)(cai)交易(yi),下至生產(chan)開(kai)發(fa)(fa)、終端銷售,已基本貫穿(chuan)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)醫藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)產(chan)業(ye)(ye)(ye)(ye)(ye)鏈的(de)(de)(de)上(shang)(shang)、中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)、下游產(chan)業(ye)(ye)(ye)(ye)(ye),業(ye)(ye)(ye)(ye)(ye)務(wu)(wu)滲透中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)醫藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)全(quan)(quan)產(chan)業(ye)(ye)(ye)(ye)(ye)鏈的(de)(de)(de)各(ge)個(ge)關鍵(jian)環節,有(you)(you)(you)效地(di)整合全(quan)(quan)產(chan)業(ye)(ye)(ye)(ye)(ye)鏈資源。公(gong)司先后在全(quan)(quan)國(guo)(guo)(guo)(guo)(guo)(guo)各(ge)地(di)投資建(jian)立140多家(jia)(jia)(jia)(jia)(jia)(jia)涵蓋藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)材(cai)(cai)種植、中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)材(cai)(cai)交易(yi)市場、現代物(wu)流中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)心(xin)和(he)產(chan)業(ye)(ye)(ye)(ye)(ye)基地(di)等(deng)業(ye)(ye)(ye)(ye)(ye)務(wu)(wu)的(de)(de)(de)企(qi)業(ye)(ye)(ye)(ye)(ye),管(guan)理的(de)(de)(de)交易(yi)市場交易(yi)規(gui)模占全(quan)(quan)國(guo)(guo)(guo)(guo)(guo)(guo)的(de)(de)(de)60%以上(shang)(shang),做(zuo)出(chu)了(le)多個(ge)方面的(de)(de)(de)國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)(jia)(jia)標(biao)(biao)(biao)準:制(zhi)定中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)飲(yin)片國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)(jia)(jia)標(biao)(biao)(biao)準以及生產(chan)管(guan)理GMP、小包裝、色標(biao)(biao)(biao)管(guan)理、炮(pao)制(zhi)等(deng)國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)(jia)(jia)標(biao)(biao)(biao)準。參與國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)(jia)(jia)商務(wu)(wu)部(bu)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)材(cai)(cai)等(deng)級分類標(biao)(biao)(biao)準制(zhi)訂。承擔(dan)編(bian)(bian)制(zhi)和(he)運營(ying)國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)(jia)(jia)發(fa)(fa)改(gai)委批(pi)準、授(shou)權發(fa)(fa)布(bu)的(de)(de)(de)全(quan)(quan)國(guo)(guo)(guo)(guo)(guo)(guo)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)材(cai)(cai)價格指數——康(kang)美·中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)(guo)(guo)(guo)(guo)(guo)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)材(cai)(cai)價格指數。推出(chu)“實(shi)體(ti)與虛擬市場相結合”的(de)(de)(de)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)材(cai)(cai)大宗現貨交易(yi)平臺(tai),開(kai)創(chuang)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)材(cai)(cai)交易(yi)新(xin)模式(shi)。承擔(dan)編(bian)(bian)制(zhi)700多項(xiang)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)醫藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)編(bian)(bian)碼的(de)(de)(de)國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)(jia)(jia)標(biao)(biao)(biao)準,助力實(shi)施(shi)統(tong)一的(de)(de)(de)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)、中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)方劑、中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)供應鏈編(bian)(bian)碼體(ti)系(xi)、成為國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)(jia)(jia)信息化醫療機構服(fu)務(wu)(wu)平臺(tai)試(shi)點(dian)(dian)單(dan)位,康(kang)美智慧藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)房被(bei)列為國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)(jia)(jia)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)醫藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)服(fu)務(wu)(wu)標(biao)(biao)(biao)準化研(yan)究基地(di),打造了(le)互(hu)聯網時代的(de)(de)(de)就醫用(yong)(yong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)新(xin)模式(shi)。是承擔(dan)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)典(dian)會動(dong)物(wu)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)飲(yin)片炮(pao)制(zhi)規(gui)范(fan)項(xiang)目企(qi)業(ye)(ye)(ye)(ye)(ye),獲(huo)批(pi)國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)(jia)(jia)民營(ying)網絡醫院資質。組建(jian)了(le)由(you)6位中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)科院、工程(cheng)院院士(shi)及眾多國(guo)(guo)(guo)(guo)(guo)(guo)醫大師組成的(de)(de)(de)專家(jia)(jia)(jia)(jia)(jia)(jia)委員會,在廣州和(he)北京設立康(kang)美藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)物(wu)研(yan)究院,擁(yong)有(you)(you)(you)“國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)(jia)(jia)企(qi)業(ye)(ye)(ye)(ye)(ye)技(ji)術(shu)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)心(xin)”等(deng)20多個(ge)國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)(jia)(jia)及省(sheng)部(bu)級研(yan)發(fa)(fa)平臺(tai)和(he)14個(ge)自主研(yan)發(fa)(fa)平臺(tai),已開(kai)展中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)國(guo)(guo)(guo)(guo)(guo)(guo)際(ji)化、中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)(yao)標(biao)(biao)(biao)準化等(deng)國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)(jia)(jia)及省(sheng)部(bu)級重大項(xiang)目近百個(ge),主持和(he)參加制(zhi)定國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)(jia)(jia)、行(xing)業(ye)(ye)(ye)(ye)(ye)標(biao)(biao)(biao)準數十項(xiang),獲(huo)批(pi)國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)(jia)(jia)或國(guo)(guo)(guo)(guo)(guo)(guo)際(ji)組織認證的(de)(de)(de)實(shi)驗室3個(ge),獲(huo)得省(sheng)級及以上(shang)(shang)科技(ji)獎勵(li)15項(xiang)。擁(yong)有(you)(you)(you)發(fa)(fa)明專利(li)(li)、實(shi)用(yong)(yong)新(xin)型專利(li)(li)、外觀設計專利(li)(li)、軟件著作權等(deng)知識(shi)產(chan)權達620余(yu)項(xiang),是國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)(jia)(jia)技(ji)術(shu)創(chuang)新(xin)示范(fan)企(qi)業(ye)(ye)(ye)(ye)(ye)和(he)國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)(jia)(jia)智能制(zhi)造試(shi)點(dian)(dian)示范(fan)企(qi)業(ye)(ye)(ye)(ye)(ye)、國(guo)(guo)(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)(jia)(jia)知識(shi)產(chan)權優(you)勢企(qi)業(ye)(ye)(ye)(ye)(ye)。
公司在(zai)(zai)全國建立(li)了17個中(zhong)藥飲(yin)片和醫藥現代化生(sheng)產基地,與超過2000家醫療機構、20萬家藥店建立(li)了合作關系,年門診總量(liang)達到2.5億人(ren)次以上,投(tou)資管(guan)理康(kang)美醫院、康(kang)美梅河(he)口中(zhong)心醫院、康(kang)美開原市中(zhong)心醫院、康(kang)美通城人(ren)民(min)醫院、康(kang)美柳河(he)中(zhong)心醫院等多家公立(li)醫院,在(zai)(zai)100多家公立(li)醫院開展醫藥物(wu)流延伸配送(song)服務。
公司以(yi)(yi)國(guo)(guo)(guo)家(jia)中(zhong)醫(yi)藥(yao)管(guan)(guan)理局(ju)信(xin)息(xi)化醫(yi)療(liao)服(fu)務平臺試(shi)點(dian)單位為(wei)(wei)契機,在中(zhong)醫(yi)藥(yao)行業把(ba)互聯網(wang)深度布局(ju)全產業鏈(lian)(lian)中(zhong),以(yi)(yi)中(zhong)藥(yao)飲片為(wei)(wei)核心,以(yi)(yi)智(zhi)慧藥(yao)房(fang)(fang)為(wei)(wei)抓手,圍繞“大(da)健康(kang)+大(da)平臺+大(da)數據+大(da)服(fu)務”體系,以(yi)(yi)全產業鏈(lian)(lian)資源優勢,積極探(tan)索中(zhong)醫(yi)藥(yao)工業智(zhi)能制造4.0,打造“智(zhi)慧藥(yao)房(fang)(fang)”模(mo)式,國(guo)(guo)(guo)務院辦公廳、國(guo)(guo)(guo)家(jia)衛(wei)健委、國(guo)(guo)(guo)家(jia)中(zhong)醫(yi)藥(yao)管(guan)(guan)理局(ju)先后發文,明確“鼓勵有(you)條件的醫(yi)療(liao)機構推進‘智(zhi)慧藥(yao)房(fang)(fang)’建設(she),實現(xian)處方系統與藥(yao)房(fang)(fang)配方系統無縫(feng)對接。”“智(zhi)慧藥(yao)房(fang)(fang)”模(mo)式上升為(wei)(wei)行業標準,為(wei)(wei)患(huan)者提供了“一(yi)站式”藥(yao)事服(fu)務,實現(xian)了“讓(rang)信(xin)息(xi)多跑路(lu),讓(rang)群眾少跑腿”。
康美藥(yao)(yao)業(ye)將以“經(jing)營(ying)有界、突出主業(ye)”為(wei)(wei)(wei)指導思(si)想,圍繞“聚焦(jiao)核心業(ye)務(wu)、提(ti)高核心競爭力(li)”的(de)工(gong)作(zuo)方針(zhen),明確(que)以中藥(yao)(yao)飲片(pian)及其制品為(wei)(wei)(wei)核心業(ye)務(wu),通(tong)過有機整(zheng)合(he)公司(si)的(de)產業(ye)布(bu)局優勢(shi)(shi)、線上線下(xia)互相強化的(de)采(cai)購優勢(shi)(shi)、研(yan)發制成與質管優勢(shi)(shi)、營(ying)銷(xiao)服務(wu)優勢(shi)(shi),成為(wei)(wei)(wei)具(ju)備中醫藥(yao)(yao)全產業(ye)鏈(lian)動態整(zheng)合(he)和規范經(jing)營(ying)能(neng)力(li)的(de)標桿企業(ye)。